Alloy Therapeutics
Updates & Highlights
Business Wire · 1 day ago
Alloy Therapeutics Selected to Join the World Economic Forum’s Unicorns Community
BioSpace · 8 days ago
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
Business Wire · 8 days ago
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Alloy Therapeutics?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAlloy Therapeutics Selected to Join the World Economic Forum’s Unicorns Community
Alloy Therapeutics Selected to Join the World Economic Forum’s Unicorns Community
Business Wire · 1 day ago
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
BioSpace · 8 days ago
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List
Business Wire · 8 days ago
Alloy Therapeutics secures $1B valuation
Alloy Therapeutics secures $1B valuation
The Business Journals · 3 months ago
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
BioSpace · 3 months ago
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
Business Wire · 3 months ago
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
BioSpace · 5 months ago
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
Business Wire · 5 months ago
Staying private: Alloy Therapeutics’ $40m Series E fuels company expansion
Staying private: Alloy Therapeutics’ $40m Series E fuels company expansion
BioXconomy · 5 months ago
Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure
Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure
Pulse 2.0 · 5 months ago
Alloy Therapeutics Raises $40M in Series E Funding
Alloy Therapeutics Raises $40M in Series E Funding
FinSMEs · 5 months ago
Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure
Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure
BioSpace · 5 months ago
Alloy Therapeutics Secures $40M To Accelerate AI Drug Development
Alloy Therapeutics Secures $40M To Accelerate AI Drug Development
Ventureburn · 5 months ago
Alloy Therapeutics Secures $40M To Accelerate AI Drug Development
Alloy Therapeutics Secures $40M To Accelerate AI Drug Development
Ventureburn · 5 months ago
Alloy Therapeutics Raises $40M Series E at $1B Valuation to Expand AI-Driven Drug Development Platform
Alloy Therapeutics Raises $40M Series E at $1B Valuation to Expand AI-Driven Drug Development Platform
citybiz · 5 months ago
Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure
Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure
Business Wire · 5 months ago
Boost for Cambridge as US company Alloy Therapeutics shows real Vigilance
Boost for Cambridge as US company Alloy Therapeutics shows real Vigilance
Business Weekly · 5 months ago
Biogen to use Alloy Therapeutics’ Anticlastic ASO platform
Biogen to use Alloy Therapeutics’ Anticlastic ASO platform
BioWorld News · 5 months ago
Biogen partners with Alloy Therapeutics to adva...
Biogen partners with Alloy Therapeutics to adva...
Pluang · 5 months ago
Alloy Therapeutics Enters Into Multi-Target Collaboration And License Agreement With Biogen For Use Of Alloy’S Anticlastic™ Aso Platform
Alloy Therapeutics Enters Into Multi-Target Collaboration And License Agreement With Biogen For Use Of Alloy’S Anticlastic™ Aso Platform
TradingView · 5 months ago